Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Single gene therapy injection tested to halt blindness

NCT ID NCT02652767

Summary

This study tested whether a single injection of an experimental gene therapy, called GS010, could improve vision in people with a rare inherited eye disease called Leber Hereditary Optic Neuropathy (LHON). The trial involved 39 participants who had recently started losing their vision (within the last 6 months). Researchers compared the effects of the real injection to a sham (placebo) procedure to see if the therapy was effective.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPTIC, ATROPHY, HEREDITARY, LEBER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre National Hospitalier d'Ophtalmologie des Quinze-VingtCentre National Hospitalier d'Ophtalmologie des Quinze-Vingt

    Paris, Paris, France

  • Department of Neurology, University of Munich, Friedrich-Baur-Institute

    Munich, 80336, Germany

  • Department of Ophthalmology, Emory University School of Medicine

    Atlanta, Georgia, 30322, United States

  • Doheny Eye Center, University of California, Los Angeles

    Los Angeles, California, 91105, United States

  • IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Ospedale Bellaria

    Bologna, Bologna, Italy

  • Moorfields Eye Hospital NHS Foundation Trust

    London, EC1V 2PD, United Kingdom

  • Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University

    Philadelphia, Pennsylvania, 19107, United States

Conditions

Explore the condition pages connected to this study.